Schizophrenia Trial, Recruiting NCT07003529 Sponsor: Centre Hospitalier Universitaire de Nīmes Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07003529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must have freely agreed to take part and signed a consent form
  • You must be covered by a health insurance plan
  • You must have been diagnosed with schizophrenia according to standard criteria (DSM-5), confirmed through a clinical interview
  • Your schizophrenia must have been present for 20 years or less
  • You must currently be receiving psychiatric care, either as a hospital inpatient, as an outpatient, or through a mandatory community psychiatric care programme
  • Your overall health must be considered suitable for brain scanning, as judged by your doctor
  • You must be able to understand, read, and write French

For one specific group within the trial:

  • You must be experiencing hallucinations and have had them in the past 15 days, with a score of 4 or higher on a specific hallucination-related rating scale (confirm with trial site)

For the comparison group within the trial:

  • You must not be experiencing any hallucinations and must have had none in the past 15 days, with a score of 1 on that same rating scale (confirm with trial site)

Who may not be able to join:

  • People who are under a legal protection order or state guardianship
  • People who cannot have an MRI scan — for example, due to severe claustrophobia or other medical reasons
  • People who are deaf, whether from birth or due to illness or injury
  • People considered to be at risk of suicide, as judged by their doctor
  • People with moderate to severe learning disabilities, based on their medical records
  • People with moderate to severe memory or thinking difficulties, based on their medical records
  • People currently taking certain anticholinergic medications (such as Akineton, Artane, or Lepticur)
  • People who have taken part in another clinical drug or medical device trial within the past 3 months
  • People under any form of court-ordered legal protection
  • Women who are pregnant, in labour, or breastfeeding
  • People who are not able to give their own consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martin Pastre, CHU de Nimes

Phone: 06 95 55 68 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Nīmes
Registry
ClinicalTrials.gov
Start date
12 September 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Resting state of functional connectivity of the inferior colliculi region with other regions of the auditory network between groups; Default mode network patterns between groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov